Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis
Biomedical Journal
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “General Medicine”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis. // Biomedical Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2319417026000752?dgcid=rss_sd_all
Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis. Biomedical Journal. https://www.sciencedirect.com/science/article/pii/S2319417026000752?dgcid=rss_sd_all
“Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis.” Biomedical Journal.
@article{article38355,
title = {Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis},
journal = {Biomedical Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2319417026000752?dgcid=rss_sd_all}
}